A breath test for malignant mesothelioma using an electronic nose
暂无分享,去创建一个
Deborah H Yates | D. Yates | P. Thomas | Craig Lewis | Paul S Thomas | Eleanor A Chapman | Emily Stone | C. Lewis | E. Stone
[1] Olaf Tietje,et al. Prediction of lung cancer using volatile biomarkers in breath , 2005 .
[2] Heng Tao Shen,et al. Principal Component Analysis , 2009, Encyclopedia of Biometrics.
[3] S. Skates,et al. Comparison of Osteopontin, Megakaryocyte Potentiating Factor, and Mesothelin Proteins as Markers in the Serum of Patients with Malignant Mesothelioma , 2008, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[4] A. Savitzky,et al. Smoothing and Differentiation of Data by Simplified Least Squares Procedures. , 1964 .
[5] P. Sterk,et al. An electronic nose distinguishes exhaled breath of patients with Malignant Pleural Mesothelioma from controls. , 2012, Lung cancer.
[6] H. Pass,et al. Current status of screening for malignant pleural mesothelioma. , 2009, Seminars in thoracic and cardiovascular surgery.
[7] S. Weitzman,et al. The molecular basis of asbestos induced lung injury , 1999, Thorax.
[8] M. Phillips,et al. Metabolic and environmental origins of volatile organic compounds in breath. , 1994, Journal of clinical pathology.
[9] Kevin Gleeson,et al. Detection of lung cancer with volatile markers in the breath. , 2003, Chest.
[10] L. Trizio,et al. Chemical characterization of exhaled breath to differentiate between patients with malignant plueral mesothelioma from subjects with similar professional asbestos exposure , 2010, Analytical and bioanalytical chemistry.
[11] M. Copin,et al. Soluble mesothelin-related peptides in the diagnosis of malignant pleural mesothelioma. , 2006, American journal of respiratory and critical care medicine.
[12] Onofrio Resta,et al. An electronic nose in the discrimination of patients with non-small cell lung cancer and COPD. , 2009, Lung cancer.
[13] H. Pass,et al. Soluble mesothelin-related peptide level elevation in mesothelioma serum and pleural effusions. , 2008, The Annals of thoracic surgery.
[14] S. Anderson,et al. Airway responsiveness : standardized challenge testing with pharmacological, physical and sensitizing stimuli in adults , 1993 .
[15] D. Yates,et al. Incidence trends and gender differences in malignant mesothelioma in New South Wales, Australia. , 2007, Scandinavian journal of work, environment & health.
[16] Eun‐Kee Park,et al. Asbestos-related occupational lung diseases in NSW, Australia and potential exposure of the general population. , 2008, Industrial health.
[17] Anton Amann,et al. Lung cancer detection by proton transfer reaction mass-spectrometric analysis of human breath gas , 2007 .
[18] M. Mcculloch,et al. Diagnostic Accuracy of Canine Scent Detection in Early- and Late-Stage Lung and Breast Cancers , 2006, Integrative cancer therapies.
[19] D. Yates,et al. An electronic nose in the discrimination of breath from smokers and non-smokers: a model for toxin exposure , 2009, Journal of breath research.
[20] Tarek Mekhail,et al. Diagnosis of lung cancer by the analysis of exhaled breath with a colorimetric sensor array , 2007, Thorax.
[21] Deborah H Yates,et al. Exhaled breath condensate biomarkers in asbestos-related lung disorders. , 2009, Respiratory medicine.
[22] J. Hankinson,et al. Standardisation of spirometry , 2005, European Respiratory Journal.
[23] J. Leigh,et al. After Helsinki: a multidisciplinary review of the relationship between asbestos exposure and lung cancer, with emphasis on studies published during 1997-2004. , 2004, Pathology.
[24] M. Robinson,et al. Statement on malignant mesothelioma in the UK , 2002, Thorax.
[25] I. Horváth,et al. Exhaled biomarkers in lung cancer , 2009, European Respiratory Journal.
[26] Peter J Sterk,et al. An electronic nose in the discrimination of patients with asthma and controls. , 2007, The Journal of allergy and clinical immunology.
[27] L. Garneau. The diagnosis of nonmalignant diseases related to asbestos , 1986 .
[28] D. Yates,et al. Breath analysis in asbestos-related disorders: a review of the literature and potential future applications , 2010, Journal of breath research.
[29] Niki Fens,et al. Exhaled breath profiling enables discrimination of chronic obstructive pulmonary disease and asthma. , 2009, American journal of respiratory and critical care medicine.
[30] R. Welsh,et al. Age, tumor size, type of surgery, and gender predict survival in early stage (stage I and II) non-small cell lung cancer after surgical resection. , 2010, Lung cancer.
[31] P. Mazzone,et al. Detection of lung cancer by sensor array analyses of exhaled breath. , 2005, American journal of respiratory and critical care medicine.
[32] J. Austin,et al. Detection of lung cancer using weighted digital analysis of breath biomarkers. , 2008, Clinica chimica acta; international journal of clinical chemistry.
[33] R. Cataneo,et al. Volatile organic compounds in breath as markers of lung cancer: a cross-sectional study , 1999, The Lancet.
[34] J. Roca,et al. Standardization of the measurement of transfer factor (diffusing capacity). Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. , 1993, The European respiratory journal. Supplement.
[35] J. Austin,et al. Prediction of lung cancer using volatile biomarkers in breath. , 2007, Cancer biomarkers : section A of Disease markers.
[36] Eun‐Kee Park,et al. Soluble mesothelin-related protein in an asbestos-exposed population: the dust diseases board cohort study. , 2008, American journal of respiratory and critical care medicine.
[37] A. Musk,et al. Soluble mesothelin-related protein--a blood test for mesothelioma. , 2005, Lung cancer.
[38] A. Tossavainen. Asbestos , asbestosis , and cancer : the Helsinki criteria for diagnosis and altribu tion , 2022 .
[39] Linda Humphrey,et al. Lung Cancer Screening with Sputum Cytologic Examination, Chest Radiography, and Computed Tomography: An Update for the U.S. Preventive Services Task Force , 2004, Annals of Internal Medicine.
[40] D. Yates,et al. Projected mesothelioma incidence in men in New South Wales , 2007, Occupational and Environmental Medicine.
[41] Philipp Lirk,et al. Mass spectrometric profile of exhaled breath—field study by PTR-MS , 2005, Respiratory Physiology & Neurobiology.
[42] J. Roca,et al. Standardization of the measurement of transfer factor (diffusing capacity) , 1993, European Respiratory Journal.